|Last Price$45.91||Day Change (%)-0.02%|
|Open Price$45.95||Day Change ($)-0.01|
|Day Range45.91–45.98||52-Week Range22.11–46.01|
As of Wed 01/28/2015 06:46 PM EST | USD
NPS PHARMACEUTICALS , INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals , Inc. Over the Proposed Sale of the Company to Shire Plc - NPSP
NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc
Robbins Arroyo LLP: Acquisition of NPS Pharmaceuticals , Inc. ( NPSP ) by Shire PLC (SHP) May Not Be in Shareholders' Best Interests
NPS Pharmaceuticals , Inc. Acquisition By Shire Plc May Not Be In The Best Interests Of NPSP Shareholders
EQUITY ALERT: The Rosen Law Firm Announces Investigation of NPS Pharmaceuticals Concerning its Proposed Sale to Shire – NPSP
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of NPS Pharmaceuticals , Inc.
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals , Inc. Stockholders
LONDON MARKETS: U.K. Stocks Fall As Investors Absorb Syriza Win
U.K. stocks fall as investors absorb Syriza win
Ryan & Maniskas, LLP Announces Investigation of NPS Pharmaceuticals , Inc.